More Bad News: Alexion Soliris Test Failure

21 Dec

Alexion Pharmaceuticals quietly reported late Wednesday that its Phase 2/3 trial of eculizumab (Soliris) had failed to reach its primary endpoint for the prevention of delayed graft function in recipients of deceased donor kidneys. The news rounds out a tumultuous final … Read More »

Psioxus Doubts And Bristol-myers Squibb, $936 Deal

21 Dec

PsiOxus Therapeutics has signed a second agreement with Bristol-Myers Squibb (BMS), this time for worldwide rights to its ‘armed’ oncolytic virus NG-348, currently in the preclinical research phase. The new deal comes six months after the two companies joined forces … Read More »

Brain Training To Enhance Confidence

19 Dec

Eating well, exercising, and being socially active are some factors that can help raise self-esteem. For some people, however, the road to confidence is much more challenging. Now, researchers suggest it may be possible to train the brain to boost … Read More »